v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   409,786,957    
Beginning balance at Dec. 31, 2024 $ 340,664 $ 606,505 $ 18,977 $ (284,818)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issued from financing activities (in shares)   33,551,854    
Issued from financing activities 18,441 $ 18,441    
Share-based compensation and related share issuances (in shares)   20,000    
Share-based compensation and related share issuances 58 $ 52 6  
Net loss (41,205)     (41,205)
Ending balance (in shares) at Mar. 31, 2025   443,358,811    
Ending balance at Mar. 31, 2025 317,958 $ 624,998 18,983 (326,023)
Beginning balance (in shares) at Dec. 31, 2024   409,786,957    
Beginning balance at Dec. 31, 2024 340,664 $ 606,505 18,977 (284,818)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation and related share issuances (in shares)   358,480    
Share-based compensation and related share issuances   $ 289    
Net loss (71,420)      
Ending balance (in shares) at Jun. 30, 2025   814,697,291    
Ending balance at Jun. 30, 2025 463,540 $ 790,183 29,595 (356,238)
Beginning balance (in shares) at Mar. 31, 2025   443,358,811    
Beginning balance at Mar. 31, 2025 317,958 $ 624,998 18,983 (326,023)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issued from financing activities (in shares)   371,000,000    
Issued from financing activities 175,465 $ 164,948 10,517  
Share-based compensation and related share issuances (in shares)   338,480    
Share-based compensation and related share issuances 332 $ 237 95  
Net loss (30,215)     (30,215)
Ending balance (in shares) at Jun. 30, 2025   814,697,291    
Ending balance at Jun. 30, 2025 $ 463,540 $ 790,183 29,595 (356,238)
Beginning balance (in shares) at Dec. 31, 2025 827,230,192 827,230,192    
Beginning balance at Dec. 31, 2025 $ 346,773 $ 799,855 30,583 (483,665)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issued from financing activities (in shares)   11,127,290    
Issued from financing activities 18,531 $ 18,531    
Issued on exercise of warrants (in shares)   13,603,447    
Exercise of warrants 9,524 $ 10,295 (771)  
Share-based compensation and related share issuances (in shares)   1,520,468    
Share-based compensation and related share issuances 2,669 $ 2,558 111  
Net loss (78,601)     (78,601)
Ending balance (in shares) at Mar. 31, 2026   853,481,397    
Ending balance at Mar. 31, 2026 $ 298,896 $ 831,239 29,923 (562,266)
Beginning balance (in shares) at Dec. 31, 2025 827,230,192 827,230,192    
Beginning balance at Dec. 31, 2025 $ 346,773 $ 799,855 30,583 (483,665)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issued on exercise of warrants (in shares) 541,341 22,103,447    
Exercise of warrants   $ 16,727    
Share-based compensation and related share issuances (in shares)   1,987,517    
Share-based compensation and related share issuances   $ 3,298    
Net loss $ (131,128)      
Ending balance (in shares) at Jun. 30, 2026 865,901,683 865,901,683    
Ending balance at Jun. 30, 2026 $ 258,047 $ 843,207 29,633 (614,793)
Beginning balance (in shares) at Mar. 31, 2026   853,481,397    
Beginning balance at Mar. 31, 2026 298,896 $ 831,239 29,923 (562,266)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issued from financing activities (in shares)   3,453,237    
Issued from financing activities 4,796 $ 4,796    
Issued on exercise of warrants (in shares)   8,500,000    
Exercise of warrants 5,950 $ 6,432 (482)  
Share-based compensation and related share issuances (in shares)   467,049    
Share-based compensation and related share issuances 932 $ 740 192  
Net loss $ (52,527)     (52,527)
Ending balance (in shares) at Jun. 30, 2026 865,901,683 865,901,683    
Ending balance at Jun. 30, 2026 $ 258,047 $ 843,207 $ 29,633 $ (614,793)